H. Sievert

Journal of the American College of Cardiology · 2004–2014

A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom H. Sievert trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. John K. Kruschke

Who trusts H. Sievert overall

  1. Vivek Y. Reddy

Papers from H. Sievert's perspective

Ordered by how strongly the researchers H. Sievert trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Apixaban in patients with atrial fibrillation. (New England Journal of Medicine)
  2. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation (Annals of Internal Medicine)
  3. Bayesian data analysis.
  4. The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation (Annals of Internal Medicine)
  5. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special… (Europace)
  6. Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort
  7. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart… (Circulation)
  8. Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin
  9. Why do patients with atrial fibrillation not receive warfarin? (Archives of Internal Medicine)
  10. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. (New England Journal of Medicine)

Their papers